A Study of AP505 Injection in Patients With Advanced Malignant Solid Tumors

NCT06723964 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: AP505

Sponsor

AP Biosciences Inc.